| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $117.7M | +80.2% |
| SG&A Expense | $48.6M | +26.0% |
| Operating Income | -$166.3M | -60.0% |
| Interest Expense | $5.5M | +140.1% |
| Pre-tax Income | -$183.8M | -69.1% |
| Income Tax | $0 | — |
| Net Income | -$183.8M | -69.1% |
| EPS (Basic) | -$2.06 | -33.8% |
| EPS (Diluted) | -$2.06 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $257.8M | -5.8% |
| Short-term Investments | $153.8M | — |
| Current Assets | $419.3M | +48.9% |
| Total Assets | $440.1M | +45.7% |
| Current Liabilities | $66.7M | +71.7% |
| Long-term Debt | $40.6M | +85.7% |
| Total Liabilities | $107.8M | +77.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$131.6M | -66.3% |
| Investing Cash Flow | -$151.6M | — |
| Financing Cash Flow | $267.3M | +5.6% |
| -33.8% |
| Stockholders' Equity |
| $332.3M |
| +37.6% |